Ovid Therapeutics Inc. (OVID) Net income 2016–2025
Ovid Therapeutics Inc. (OVID) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$17.4MFY2025 · since FY2016: -$22.4M → -$17.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$17.4M | +34.1% |
| FY2024 | -$26.4M | +49.5% |
| FY2023 | -$52.3M | +3.4% |
| FY2022 | -$54.2M | -144.1% |
| FY2021 | $122.8M | +251.6% |
| FY2020 | -$81.0M | -34.0% |
| FY2019 | -$60.5M | -16.3% |
| FY2018 | -$52.0M | +19.8% |
| FY2017 | -$64.8M | -189.1% |
| FY2016 | -$22.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More OVID financial trends
OVID RevenueOVID Net marginOVID Gross profitOVID Gross marginOVID Operating incomeOVID Operating marginOVID Operating cash flowOVID Free cash flowOVID Capital expendituresOVID Return on equityOVID Stock buybacksOVID Dividends paidOVID Total assetsOVID Total liabilitiesOVID Shareholders’ equityOVID overview →